Career history of Jon T. Holmlund
Former positions of Jon T. Holmlund
| Companies | Position | Start | End |
|---|---|---|---|
| GALERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2012 | 31/12/2022 |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Chief Tech/Sci/R&D Officer | 01/04/2004 | 01/11/2007 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/1997 | 01/03/2004 |
Aspire IRB LLC
 Aspire IRB LLC Miscellaneous Commercial ServicesCommercial Services Aspire IRB LLC operates as an independent review board that provides human subject protection oversight in clinical trials for life science companies. The private company is based in San Diego, CA and has subsidiaries in the United States. | Chief Tech/Sci/R&D Officer | - | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Training of Jon T. Holmlund
| State University of New York at Buffalo | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| GALERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Aspire IRB LLC
Aspire IRB LLC Miscellaneous Commercial ServicesCommercial Services Aspire IRB LLC operates as an independent review board that provides human subject protection oversight in clinical trials for life science companies. The private company is based in San Diego, CA and has subsidiaries in the United States. | Commercial Services |
- Stock Market
- Insiders
- Jon T. Holmlund
- Experience
